This website uses cookies to enhance the user experience.
ME

Madeleine Engen1986

Shareholdings
5
25
Norway Business roles
13

Roles

Management

NameRoleTotal operating incomeTotal equityShares
E
ENGEN MEDICAL AS
Managing Director/CEO
-
-224,700
100 %
directly
N
NOWO INVEST AS
Managing Director/CEO
-
41,647,739
100 %
directly
E
ERIK ENGEN EFTF AS
Managing Director/CEO
-
52,934,453
70 %
indirectly
H
HOVSTIEN 15 AS
Managing Director/CEO
-
83,483,275
70 %
directly
E
ENGEN & NILSEN FAMILY INVEST AS
Managing Director/CEO
-
-2,632,292
50 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
E
ENGEN MEDICAL AS
Chairman
-
-224,700
100 %
directly
N
NOWO INVEST AS
Chairman
-
41,647,739
100 %
directly
E
ERIK ENGEN EFTF AS
Chairman
-
52,934,453
70 %
indirectly
H
HOVSTIEN 15 AS
Chairman
-
83,483,275
70 %
directly
E
ENGEN & NILSEN FAMILY INVEST AS
Board Member
-
-2,632,292
50 %
indirectly
C
C-MEDICAL GROUP AS
Board Member
73,000
213,759,498
8.22 %
indirectly
G
GYNEKOLOG MADELEINE ENGEN
Holder
-
-
-
C
CEMA HEALTH AS
Deputy Chair
-
-
-
Last update: May 26, 2025

Related industries3

Direct relationships5

Shares owned by Madeleine Engen

NameShare classTotal operating incomeTotal equityShare
E
ENGEN MEDICAL AS
Ordinære aksjer
0
-224,700
100 %
directly
N
NOWO INVEST AS
Ordinære aksjer
0
41,647,739
100 %
directly
H
HOVSTIEN 15 AS
Ordinære aksjer
0
83,483,275
70 %
directly
E
ERIK ENGEN EFTF AS
0
52,934,453
70 %
indirectly
E
ENGEN & NILSEN FAMILY INVEST AS
0
-2,632,292
50 %
indirectly
C
C-MEDICAL MOELV AS
7,363,925
-7,331,963
8.22 %
indirectly
O
OSLO ORTOPEDSENTER AS
55,261
1,720,644
8.22 %
indirectly
C
C-MEDICAL AS
83,270,495
275,709,990
8.22 %
indirectly
C
C-MEDICAL GROUP AS
73,000
213,759,498
8.22 %
indirectly
S
SKI UROLOGISKE SPESIALISTSENTER AS
4,096,016
728,561
8.22 %
indirectly
C
C-MEDICAL SARPSBORG AS
7,346,366
-2,942,031
8.22 %
indirectly
B
BJØNNDALSVEIEN 7 EIENDOM AS
9,104,324
1,965,448
7 %
indirectly
B
BJØNNDALSVEIEN 7 EIENDOMSINVEST AS
0
20,024,276
7 %
indirectly
C
C-MEDICAL STAVANGER AS
1,045,991
227,356
4.93 %
indirectly
C
COLOSSEUM FAUST AS
21,098,090
-13,211,086
4.93 %
indirectly
N
NORDRE FOKSERØD 14 AS
8,827,791
38,643,203
3.98 %
indirectly
B
BORGESKOGEN LOGISTIKKINVEST AS
0
65,903,265
3.42 %
indirectly
B
BORGESKOGEN 73 AS
10,548,448
64,074,865
3.42 %
indirectly
K
KRISTIANSAND OFFENTLIG EIENDOM AS
0
25,777,285
3.4 %
indirectly
F
FLESLAND KONTORINVEST AS
0
14,648,310
3.14 %
indirectly
F
FLESLAND EIENDOMSINVEST AS
0
34,082,000
3.14 %
indirectly
B
BYGGVARE EIENDOMSINVEST AS
0
61,057,371
2.8 %
indirectly
S
SKIEN INDUSTRIBYGG AS
0
42,250,574
2.8 %
indirectly
K
KOMBIEIENDOM SKIEN AS
14,996,449
28,963,014
2.8 %
indirectly
B
BYGGVARE EIENDOM AS
0
42,133,607
2.8 %
indirectly
T
TERNINGEN INVEST AS
0
256,175,173
0.63 %
indirectly
E
ELVERUM EIENDOMSINVEST AS
0
50,799,049
0.63 %
indirectly
T
TERNINGEN EIENDOMSHOLDING AS
0
154,828,423
0.63 %
indirectly
N
NORSKE SKOG ASA
NO0010861115
116,000,000
4,494,000,000
0.02 %
directly < 0.01 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
13,362,000
174,832,000
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025